Spots Global Cancer Trial Database for RWS of Inetetamab HER2 Positive Advanced Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: RWS of Inetetamab HER2 Positive Advanced Breast Cancer
Official Title: Real World Study of Inetetamab HER2 Positive Advanced Breast Cancer
Study ID: NCT04963608
Conditions
HER2-positive Advanced Breast Cancer
Interventions
Inetetamab
Study Description
Brief Summary: This non-Interventional study will describe and analyze the clinical use of Inetetamab in clinical practice in the treatment of HER2 positive advanced breast cancer in the real world.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
